LUPIN Company Profile
✉ Email this page to a colleague
What is the competitive landscape for LUPIN, and what generic alternatives to LUPIN drugs are available?
LUPIN has two hundred and thirty-eight approved drugs.
There are nineteen US patents protecting LUPIN drugs. There are twenty-two tentative approvals on LUPIN drugs.
There are ninety-nine patent family members on LUPIN drugs in twenty-four countries and six hundred and ninety-nine supplementary protection certificates in seventeen countries.
Summary for LUPIN
International Patents: | 99 |
US Patents: | 19 |
Tradenames: | 193 |
Ingredients: | 173 |
NDAs: | 238 |
Patent Litigation for LUPIN: | See patent lawsuits for LUPIN |
PTAB Cases with LUPIN as petitioner: | See PTAB cases with LUPIN as petitioner |
Drugs and US Patents for LUPIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lupin Ltd | BLISOVI FE 1.5/30 | ethinyl estradiol; norethindrone acetate | TABLET;ORAL-28 | 201585-001 | Nov 18, 2015 | BX | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Lupin Ltd | LORAZEPAM | lorazepam | CONCENTRATE;ORAL | 091407-001 | Feb 19, 2013 | AA | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Lupin | LEVOTHYROXINE SODIUM | levothyroxine sodium | TABLET;ORAL | 209713-010 | Jan 18, 2019 | AB1,AB2,AB3 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Lupin Ltd | JENCYCLA | norethindrone | TABLET;ORAL-28 | 091323-001 | Mar 28, 2013 | AB2 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Lupin | RAMIPRIL | ramipril | CAPSULE;ORAL | 077626-001 | Jun 9, 2008 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for LUPIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Lupin | XOPENEX HFA | levalbuterol tartrate | AEROSOL, METERED;INHALATION | 021730-001 | Mar 11, 2005 | 8,765,153 | ⤷ Sign Up |
Lupin | BROVANA | arformoterol tartrate | SOLUTION;INHALATION | 021912-001 | Oct 6, 2006 | 8,110,706 | ⤷ Sign Up |
Lupin | ANTARA (MICRONIZED) | fenofibrate | CAPSULE;ORAL | 021695-003 | Nov 30, 2004 | 7,863,331 | ⤷ Sign Up |
Lupin | BROVANA | arformoterol tartrate | SOLUTION;INHALATION | 021912-001 | Oct 6, 2006 | 7,145,036 | ⤷ Sign Up |
Lupin | XOPENEX HFA | levalbuterol tartrate | AEROSOL, METERED;INHALATION | 021730-001 | Mar 11, 2005 | 5,605,674 | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for LUPIN drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Inhalation Solution | Eq. 0.015 mg base/2 mL | ➤ Subscribe | 2009-10-01 |
➤ Subscribe | for Injection | 200 mcg/vial | ➤ Subscribe | 2015-05-01 |
➤ Subscribe | for Oral Suspension | 500 mg/5 mL | ➤ Subscribe | 2014-07-22 |
➤ Subscribe | for Injection | 100 mcg/vial and 500 mcg/vial | ➤ Subscribe | 2015-04-14 |
➤ Subscribe | Delayed-release Tablets | 20 mg | ➤ Subscribe | 2015-06-03 |
➤ Subscribe | Injection | 250 mcg/0.5 mL, 1 mL PFS | ➤ Subscribe | 2012-03-30 |
International Patents for LUPIN Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Hong Kong | 1219883 | ⤷ Sign Up |
China | 114053423 | ⤷ Sign Up |
Japan | 2012072160 | ⤷ Sign Up |
Spain | 2263051 | ⤷ Sign Up |
New Zealand | 589290 | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for LUPIN Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1534313 | CR 2015 00072 | Denmark | ⤷ Sign Up | PRODUCT NAME: PHENYLEPHRIN, HERUNDER PHENYLEPHRINHYDROCHLORID OG KETOROLAC, HERUNDER KETOROLACTROMETAMOL; REG. NO/DATE: EU/1/15/1018 20150730 |
1586316 | 11C0031 | France | ⤷ Sign Up | PRODUCT NAME: BROMFENAC, SES SELS OU HYDRATES PHARMACOLOGIQUEMENT ACCEPTABLES; REGISTRATION NO/DATE: EU/1/11/692/001 20110518 |
2137537 | 1490038-5 | Sweden | ⤷ Sign Up | PRODUCT NAME: DIMETHYL FUMARATE; REG. NO/DATE: EU/1/13/837 20140203 |
2957286 | 300962 | Netherlands | ⤷ Sign Up | PRODUCT NAME: PATIROMER SORBITEX CALCIUM; REGISTRATION NO/DATE: EU/1/17/1179 20170721 |
1467728 | C01467728/01 | Switzerland | ⤷ Sign Up | PRODUCT NAME: SACUBRITIL UND VALSARTAN; REGISTRATION NO/DATE: SWISSMEDIC-ZULASSUNG 65673 17.09.2015 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.